A label or report that states “99%+ purity” can be useful, but only when the measurement and its limits are understood. For peptides, this figure often refers to chromatographic purity estimated by HPLC area normalization. It usually does not mean that 99% of the vial’s total mass is the target peptide, and it does not establish sterility, safety or regulatory approval.
How HPLC purity is commonly estimated
In reversed-phase HPLC, components are separated as they pass through a column and are detected over time. The chromatogram contains peaks, and software integrates the area of selected peaks. A reported area percentage compares the main peak area with the total integrated peak area under the specified conditions.
That result is method-dependent. Column chemistry, mobile phase, gradient, detector wavelength, sample concentration and integration settings can change which components are separated or detected.
What a 99%+ result can indicate
- The main chromatographic peak represents at least the stated proportion of the integrated detector response under the reported method.
- Detected peptide-related impurities produced smaller integrated signals under those conditions.
- The tested sample was relatively homogeneous by that specific chromatographic measurement.
What the number does not prove by itself
- Identity — a large peak is not automatically the intended peptide. Identity requires suitable supporting evidence, often including mass spectrometry.
- Net peptide content — water, counter-ions and other non-detected or differently responding components can affect mass-based content.
- Labelled quantity — the amount in the vial requires an appropriate quantitative method.
- Sterility or endotoxin status — these require separate microbiological or endotoxin tests.
- Absence of every impurity — a detector only reports what the method can detect and resolve.
- Fitness for human or veterinary use — analytical purity is not clinical safety, efficacy or approval.
Why identity and purity should be paired
Chromatography and mass spectrometry answer complementary questions. HPLC can separate and compare components, while mass spectrometry can support molecular identity and characterize some related impurities. A professional assessment considers the full set of methods rather than treating one percentage as a complete quality profile.
Why method validation matters
ICH Q2(R2) describes a framework for showing that an analytical procedure is fit for its intended purpose. Depending on the objective, relevant characteristics can include specificity, accuracy, precision, range and robustness. A numeric result without sufficient method information is harder to evaluate or reproduce.
A practical interpretation checklist
- Which technique produced the percentage?
- Is the result area %, mass %, assay % or another measurement?
- Was identity assessed separately?
- Are the chromatogram and sample identifier available?
- Which detector and integration rules were used?
- Were quantity, water, residual solvents, sterility or endotoxins tested separately?
- Is the report traceable to the received batch?
Further reading
Learn how to read a COA, review what research peptides are, or visit the Peptara Lab Bulgaria information page.
Scientific and analytical sources
- HPLC Analysis and Purification of Peptides
- ICH Q2(R2): Validation of Analytical Procedures
- Eurachem: The Fitness for Purpose of Analytical Methods, 3rd edition
This article is for analytical education and research reference only. A purity value is not evidence of suitability for human or veterinary use.
